Patent · US Active

Use of tight junction antagonists in the treatment of acute lung injury and acute respiratory distress syndrome

US10723763B2 · kind B2 · utility

3Cited by
3References
15Claims
0Family size

Assignees

Inventors

Key dates

Filing dateAug 12, 2016
Grant dateJul 28, 2020
Priority date
Expiry dateDec 8, 2036

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K38/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present application provides compositions and methods for treating acute lung injury and acute respiratory distress syndrome. The methods include administering one or more tight junction antagonists to the lung of a subject in need thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.